Crossref journal-article
Oxford University Press (OUP)
The Journal of Immunology (286)
Abstract

AbstractThe NF-κB family of transcription factors functions broadly in the host control of immunoregulatory gene expression, inflammation, and apoptosis. Using Jurkat T cells engineered to inducibly express a transdominant repressor of IκBα, we examined the role of NF-κB in the regulation of cytokine and apoptotic gene expression. In this T cell model, as well as in primary T lymphocytes, expression of TNF-related apoptosis-inducing ligand (TRAIL) apoptotic signaling protein was dramatically down-regulated by inhibition of NF-κB binding activity. TRAIL acts through membrane death receptors to induce apoptosis of activated T lymphocytes and can be up-regulated by a variety of physiological and pharmacological inducers. However, regulation of TRAIL gene expression has not been defined. Treatment with TCR mimetics (PMA/ionomycin, PHA, and anti-CD3/CD28 Abs) resulted in a rapid increase in the expression of TRAIL mRNA and cell surface TRAIL protein. Induction of the transdominant repressor of IκBα dramatically down-regulated surface expression of TRAIL, indicating an essential role for NF-κB in the regulation of TRAIL. The induced expression of TRAIL was linked to a c-Rel binding site in the proximal TRAIL promoter at position −256 to −265; mutation of this site or an adjacent κB site resulted in a complete loss of the inducibility of the TRAIL promoter. The regulation of TRAIL expression by NF-κB may represent a general mechanism that contributes to the control of TRAIL-mediated apoptosis in T lymphocytes.

Bibliography

Baetu, T. M., Kwon, H., Sharma, S., Grandvaux, N., & Hiscott, J. (2001). Disruption of NF-κB Signaling Reveals a Novel Role for NF-κB in the Regulation of TNF-Related Apoptosis-Inducing Ligand Expression. The Journal of Immunology, 167(6), 3164–3173.

Authors 5
  1. Tudor M. Baetu (first)
  2. Hakju Kwon (additional)
  3. Sonia Sharma (additional)
  4. Nathalie Grandvaux (additional)
  5. John Hiscott (additional)
References 70 Referenced 101
  1. Wiley, S. R., K. Schooley, P. J. Smolak, W. S. Din, C. P. Huang, J. K. Nicholl, G. R. Sutherland, T. D. Smith, C. Rauch, C. A. Smith, et al 1995. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673 (10.1016/1074-7613(95)90057-8)
  2. Pitti, R. M., S. A. Marsters, S. Ruppert, C. J. Donahue, A. Moore, A. Ashkenazi. 1996. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271: 12687 (10.1074/jbc.271.22.12687)
  3. Pan, G., K. O’Rourke, A. M. Chinnaiyan, R. Gentz, R. Ebner, J. Ni, V. M. Dixit. 1997. The receptor for the cytotoxic ligand TRAIL. Science 276: 111 (10.1126/science.276.5309.111)
  4. Pan, G., J. Ni, Y. F. Wei, G. Yu, R. Gentz, V. M. Dixit. 1997. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277: 815 (10.1126/science.277.5327.815)
  5. Sheridan, J. P., S. A. Marsters, R. M. Pitti, A. Gurney, M. Skubatch, D. Baldwin, L. Ramakrishnan, C. L. Gray, K. Baker, W. I. Wood, et al 1997. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277: 818 (10.1126/science.277.5327.818)
  6. Walczak, H., M. A. Degli-Esposti, R. S. Johnson, P. J. Smolak, J. Y. Waugh, N. Boiani, M. S. Timour, M. J. Gerhart, K. A. Schooley, C. A. Smith, R. G. Goodwin, C. T. Rauch. 1997. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J. 16: 5386 (10.1093/emboj/16.17.5386)
  7. MacFarlane, M., M. Ahmad, S. M. Srinivasula, T. Fernandes-Alnemri, G. M. Cohen, E. S. Alnemri. 1997. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J. Biol. Chem. 272: 25417 (10.1074/jbc.272.41.25417)
  8. Keogh, S. A., H. Walczak, L. Bouchier-Hayes, S. J. Martin. 2000. Failure of Bcl-2 to block cytochrome c redistribution during TRAIL-induced apoptosis. FEBS Lett. 471: 93 (10.1016/S0014-5793(00)01375-2)
  9. Schneider, P., M. Thome, K. Burns, J. L. Bodmer, K. Hofmann, T. Kataoka, N. Holler, J. Tschopp. 1997. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB. Immunity 7: 831 (10.1016/S1074-7613(00)80401-X)
  10. Kischkel, F. C., D. A. Lawrence, A. Chuntharapai, P. Schow, K. J. Kim, A. Ashkenazi. 2000. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12: 611 (10.1016/S1074-7613(00)80212-5)
  11. Chaudhary, P. M., M. Eby, A. Jasmin, A. Bookwalter, J. Murray, L. Hood. 1997. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway. Immunity 7: 821 (10.1016/S1074-7613(00)80400-8)
  12. Yeh, W. C., J. L. Pompa, M. E. McCurrach, H. B. Shu, A. J. Elia, A. Shahinian, M. Ng, A. Wakeham, W. Khoo, K. Mitchell, et al 1998. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279: 1954 (10.1126/science.279.5358.1954)
  13. Hu, W. H., H. Johnson, H. B. Shu. 1999. Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-κB and JNK activation and apoptosis through distinct pathways. J. Biol. Chem. 274: 30603 (10.1074/jbc.274.43.30603)
  14. Gura, T.. 1997. How TRAIL kills cancer cells, but not normal cells. Science 277: 768 (10.1126/science.277.5327.768)
  15. Viret, C., F. S. Wong, C. A. Janeway. 1999. Designing and maintaining the mature TCR repertoire: the continuum of self-peptide:self-MHC complex recognition. Immunity 10: 559 (10.1016/S1074-7613(00)80055-2)
  16. Degli-Esposti, M. A., P. J. Smolak, H. Walczak, J. Waugh, C. P. Huang, R. F. DuBose, R. G. Goodwin, C. A. Smith. 1997. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J. Exp. Med. 186: 1165 (10.1084/jem.186.7.1165)
  17. Degli-Esposti, M. A., W. C. Dougall, P. J. Smolak, J. Y. Waugh, C. A. Smith, R. G. Goodwin. 1997. The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. Immunity 7: 813 (10.1016/S1074-7613(00)80399-4)
  18. Kayagaki, N., N. Yamaguchi, M. Nakayama, K. Takeda, H. Akiba, H. Tsutsui, H. Okamura, K. Nakanishi, K. Okumura, H. Yagita. 1999. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. J. Immunol. 163: 1906 (10.4049/jimmunol.163.4.1906)
  19. Kayagaki, N., N. Yamaguchi, M. Nakayama, H. Eto, K. Okumura, H. Yagita. 1999. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: a novel mechanism for the antitumor effects of type I IFNs. J. Exp. Med. 189: 1451 (10.1084/jem.189.9.1451)
  20. Takeda, K., Y. Hayakawa, M. J. Smyth, N. Kayagaki, N. Yamaguchi, S. Kakuta, Y. Iwakura, H. Yagita, K. Okumura. 2001. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat. Med. 7: 94 (10.1038/83416)
  21. Jeremias, I., I. Herr, T. Boehler, K. M. Debatin. 1998. TRAIL/Apo-2-ligand-induced apoptosis in human T cells. Eur. J. Immunol. 28: 143 (10.1002/(SICI)1521-4141(199801)28:01<143::AID-IMMU143>3.0.CO;2-3)
  22. Martinez-Lorenzo, M. J., M. A. Alava, S. Gamen, K. J. Kim, A. Chuntharapai, A. Pineiro, J. Naval, A. Anel. 1998. Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells. Eur. J. Immunol. 28: 2714 (10.1002/(SICI)1521-4141(199809)28:09<2714::AID-IMMU2714>3.0.CO;2-9)
  23. Martinez-Lorenzo, M. J., A. Anel, S. Gamen, I. Monle n, P. Lasierra, L. Larrad, A. Pineiro, M. A. Alava, J. Naval. 1999. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. J. Immunol. 163: 1274 (10.4049/jimmunol.163.3.1274)
  24. Baeuerle, P. A.. 1998. IκB-NF-κB structures: at the interface of inflammation control. Cell 95: 729 (10.1016/S0092-8674(00)81694-3)
  25. Huxford, T., D.-B. Huang, S. Malek, G. Ghosh. 1998. The crystal structure of the IκBα/NF-κB complex reveals mechanisms of NF-κB inactivation. Cell 95: 759 (10.1016/S0092-8674(00)81699-2)
  26. Jacobs, M. D., S. C. Harrison. 1998. Structure of an IκBα/NF-κB complex. Cell 95: 749 (10.1016/S0092-8674(00)81698-0)
  27. Beauparlant, P., R. Lin, J. Hiscott. 1996. The role of the C-terminal domain of IκBα in protein degradation and stability. J. Biol. Chem. 271: 10690 (10.1074/jbc.271.18.10690)
  28. Brown, K., G. Franzoso, L. Baldi, L. Carlson, L. Mills, Y.-C. Lin, S. Gerstberger, U. Siebenlist. 1997. The signal response of IκBα is regulated by transferable N- and C-terminal domains. Mol. Cell. Biol. 17: 3021 (10.1128/MCB.17.6.3021)
  29. Ernst, M. K., L. L. Dunn, N. R. Rice. 1995. The PEST-like sequence of IκBα is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or RelA homodimers. Mol. Cell. Biol. 15: 872 (10.1128/MCB.15.2.872)
  30. Jaffray, E., K. M. Wood, R. T. Hay. 1995. Domain organization of IκBα and the sites of interaction with NF-κB p65. Mol. Cell. Biol. 15: 2166 (10.1128/MCB.15.4.2166)
  31. Lin, R., P. Beauparlant, C. Makris, S. Meloche, J. Hiscott. 1996. Phosphorylation of IκBα in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability. Mol. Cell. Biol. 16: 1401 (10.1128/MCB.16.4.1401)
  32. Rodriguez, M. S., I. Michalopoulos, F. Arenzana-Seisdedos, R. T. Hay. 1995. Inducible degradation of IκBα in vitro and in vivo requires the acidic C-terminal domain of the protein. Mol. Cell. Biol. 15: 2413 (10.1128/MCB.15.5.2413)
  33. DiDonato, J. A., M. Hayakawa, D. M. Rothwarf, E. Zandi, M. Karin. 1997. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388: 548 (10.1038/41493)
  34. Regnier, C. H., H. Y. Song, X. Gao, D. V. Goeddel, Z. Cao, M. Rothe. 1997. Identification and characterization of an IκB kinase. Cell 90: 373 (10.1016/S0092-8674(00)80344-X)
  35. Zandi, E., D. M. Rothwarf, M. Delhase, M. Hayakawa, M. Karin. 1997. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91: 243 (10.1016/S0092-8674(00)80406-7)
  36. Yaron, A., H. Gonen, I. Alkalay, A. Hatzubai, S. Jung, S. Beyth, F. Mercurio, A. M. Manning, A. Ciechanover, Y. Ben-Neriah. 1997. Inhibition of NF-κB cellular function via specific targeting of the IκB-ubiquitin ligase. EMBO J. 21: 6486 (10.1093/emboj/16.21.6486)
  37. Yaron, A., A. Hatzubai, M. Davis, I. Lavon, S. Amit, A. M. Manning, J. S. Andersen, M. Mann, F. Mercurio, Y. Ben-Neriah. 1998. Identification of the receptor component of the IκBα-ubiquitin ligase. Nature 396: 590 (10.1038/25159)
  38. Brown, K., S. Park, T. Kanno, G. Franzoso, U. Siebenlist. 1993. Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκBα. Proc. Natl. Acad. Sci. USA 90: 2532 (10.1073/pnas.90.6.2532)
  39. Chiao, P. J., S. Miyamoto, I. M. Verma. 1994. Autoregulation of IκBα activity. Proc. Natl. Acad. Sci. USA 91: 28 (10.1073/pnas.91.1.28)
  40. Sun, S.-C., P. A. Ganchi, D. W. Ballard, W. C. Greene. 1993. NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway. Science 259: 1912 (10.1126/science.8096091)
  41. Scott, M. L., T. Fujita, H.-C. Liou, G. P. Nolan, D. Baltimore. 1993. The p65 subunit of NF-κB regulates IκB by two distinct mechanisms. Genes Dev. 7: 1266 (10.1101/gad.7.7a.1266)
  42. de Martin, R., B. Vanhove, Q. Cheng, E. Hofer, V. Csizmadia, H. Winkler, F. H. Bach. 1993. Cytokine-inducible expression in endothelial cells of an IκBα-like gene is regulated by NF-κB. EMBO J. 12: 2773 (10.1002/j.1460-2075.1993.tb05938.x)
  43. Le Bail, O., R. Schmidt-Ullrich, A. Israël. 1993. Promoter analysis of the gene encoding the IκB-α/MAD3 inhibitor of NF-κB: positive regulation by members of the rel/NF-κB family. EMBO J. 12: 5043 (10.1002/j.1460-2075.1993.tb06197.x)
  44. Kwon, H., N. Pelletier, C. DeLuca, P. Genin, S. Cisternas, R. Lin, M. A. Wainberg, J. Hiscott. 1998. Inducible expression of IκBα repressor mutants interferes with NF-κB activity and HIV-1 replication in Jurkat T cells. J. Biol. Chem. 273: 7431 (10.1074/jbc.273.13.7431)
  45. Algarte, M., H. Kwon, P. Genin, J. Hiscott. 1999. Identification by in vivo genomic footprinting of a transcriptional switch containing NF-κB and Sp1 that regulates the IκBα promoter. Mol. Cell. Biol. 19: 6140 (10.1128/MCB.19.9.6140)
  46. Gossen, M., S. Freundlieb, G. Bender, G. Müller, W. Hillen, H. Bujard. 1995. Transcriptional activation by tetracyclines in mammalian cells. Science 268: 1766 (10.1126/science.7792603)
  47. Yin, M. J., Y. Yamamoto, R. B. Gaynor. 1998. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β. Nature 396: 77 (10.1038/23948)
  48. Kopp, E., S. Ghosh. 1994. Inhibition of NF-κB by sodium salicylate and aspirin. Science 265: 956 (10.1126/science.8052854)
  49. Pierce, J. W., R. Schoenleber, G. Jesmok, J. Best, S. A. Moore, T. Collins, M. E. Gerritsen. 1997. Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem. 272: 21096 (10.1074/jbc.272.34.21096)
  50. Wang, Q., Y. Ji, X. Wang, B. M. Evers. 2000. Isolation and molecular characterization of the 5′-upstream region of the human TRAIL gene. Biochem. Biophys. Res. Commun. 276: 466 (10.1006/bbrc.2000.3512)
  51. Malinin, N. L., M. P. Boldin, A. V. Kovalenko, D. Wallach. 1997. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385: 540 (10.1038/385540a0)
  52. Fanger, N. A., C. R. Maliszewski, K. Schooley, T. S. Griffith. 1999. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J. Exp. Med. 190: 1155 (10.1084/jem.190.8.1155)
  53. Kayagaki, N., N. Yamaguchi, M. Nakayama, A. Kawasaki, H. Akiba, K. Okumura, H. Yagita. 1999. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity. J. Immunol. 162: 2639 (10.4049/jimmunol.162.5.2639)
  54. Kaplan, M. J., D. Ray, R. R. Mo, R. L. Yung, B. C. Richardson. 2000. TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages. J. Immunol. 164: 2897 (10.4049/jimmunol.164.6.2897)
  55. Barkett, M., T. D. Gilmore. 1999. Control of apoptosis by Rel/NF-κB transcription factors. Oncogene 18: 6910 (10.1038/sj.onc.1203238)
  56. Kasibhatla, S., L. Genestier, D. R. Green. 1999. Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor κB. J. Biol. Chem. 274: 987 (10.1074/jbc.274.2.987)
  57. Matsui, K., A. Fine, B. Zhu, A. Marshak-Rothstein, S. T. Ju. 1998. Identification of two NF-κB sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma. J. Immunol. 161: 3469 (10.4049/jimmunol.161.7.3469)
  58. Wang, J., M. J. Lenardo. 1997. Essential lymphocyte function associated 1 (LFA-1): intercellular adhesion molecule interactions for T cell-mediated B cell apoptosis by Fas/APO-1/CD95. J. Exp. Med. 186: 1171 (10.1084/jem.186.7.1171)
  59. Debatin, K. M., C. K. Goldman, T. A. Waldmann, P. H. Krammer. 1993. APO-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood 81: 2972 (10.1182/blood.V81.11.2972.bloodjournal81112972)
  60. Walczak, H., R. E. Miller, K. Ariail, B. Gliniak, T. S. Griffith, M. Kubin, W. Chin, J. Jones, A. Woodward, T. Le, et al 1999. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med. 5: 157 (10.1038/5517)
  61. Gruss, H. J., S. K. Dower. 1995. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood 85: 3378 (10.1182/blood.V85.12.3378.bloodjournal85123378)
  62. Katsikis, P. D., M. E. Garcia-Ojeda, E. S. Wunderlich, C. A. Smith, H. Yagita, K. Okumura, N. Kayagaki, M. Alderson, L. A. Herzenberg. 1996. Activation-induced peripheral blood T cell apoptosis is Fas independent in HIV-infected individuals. Int. Immunol. 8: 1311 (10.1093/intimm/8.8.1311)
  63. Katsikis, P. D., M. E. Garcia-Ojeda, J. F. Torres-Roca, I. M. Tijoe, C. A. Smith, L. A. Herzenberg. 1997. Interleukin-1β converting enzyme-like protease involvement in Fas- induced and activation-induced peripheral blood T cell apoptosis in HIV infection: TNF-related apoptosis-inducing ligand can mediate activation- induced T cell death in HIV infection. J. Exp. Med. 186: 1365 (10.1084/jem.186.8.1365)
  64. Clarke, P., S. M. Meintzer, S. Gibson, C. Widmann, T. P. Garrington, G. L. Johnson, K. L. Tyler. 2000. Reovirus-induced apoptosis is mediated by TRAIL. J. Virol. 74: 8135 (10.1128/JVI.74.17.8135-8139.2000)
  65. Vidalain, P. O., O. Azocar, B. Lamouille, A. Astier, C. Rabourdin-Combe, C. Servet-Delprat. 2000. Measles virus induces functional TRAIL production by human dendritic cells. J. Virol. 74: 556 (10.1128/JVI.74.1.556-559.2000)
  66. Sedger, L. M., D. M. Shows, R. A. Blanton, J. J. Peschon, R. G. Goodwin, D. Cosman, S. R. Wiley. 1999. IFN-γ mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression. J. Immunol. 163: 920 (10.4049/jimmunol.163.2.920)
  67. McCaffrey, P. G., A. E. Goldfeld, A. Rao. 1994. The role of NFATp in cyclosporin A-sensitive tumor necrosis factor-α gene transcription. J. Biol. Chem. 269: 30445 (10.1016/S0021-9258(18)43833-1)
  68. Venkataraman, L., S. J. Burakoff, R. Sen. 1995. FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells. J. Exp. Med. 181: 1091 (10.1084/jem.181.3.1091)
  69. Venkataraman, L., W. Wang, R. Sen. 1996. Differential regulation of c-Rel translocation in activated B and T cells. J. Immunol. 157: 1149 (10.4049/jimmunol.157.3.1149)
  70. Chow, W. A., J. J. Fang, J. K. Yee. 2000. The IFN regulatory factor family participates in regulation of Fas ligand gene expression in T cells. J. Immunol. 164: 3512 (10.4049/jimmunol.164.7.3512)
Dates
Type When
Created 11 years, 4 months ago (April 20, 2014, 7:30 p.m.)
Deposited 7 months, 3 weeks ago (Jan. 2, 2025, 1:56 p.m.)
Indexed 3 months, 1 week ago (May 18, 2025, 12:04 p.m.)
Issued 23 years, 11 months ago (Sept. 15, 2001)
Published 23 years, 11 months ago (Sept. 15, 2001)
Published Print 23 years, 11 months ago (Sept. 15, 2001)
Funders 0

None

@article{Baetu_2001, title={Disruption of NF-κB Signaling Reveals a Novel Role for NF-κB in the Regulation of TNF-Related Apoptosis-Inducing Ligand Expression}, volume={167}, ISSN={1550-6606}, url={http://dx.doi.org/10.4049/jimmunol.167.6.3164}, DOI={10.4049/jimmunol.167.6.3164}, number={6}, journal={The Journal of Immunology}, publisher={Oxford University Press (OUP)}, author={Baetu, Tudor M. and Kwon, Hakju and Sharma, Sonia and Grandvaux, Nathalie and Hiscott, John}, year={2001}, month=sep, pages={3164–3173} }